Literature DB >> 21796233

Cervical Cancer Tests and Treatment.

Jori S Carter1, Levi S Downs.   

Abstract

Advances in screening and treatment of cervical cancer have been made in recent years. Here we discuss tests, stages of disease, and strategies for treatment.

Entities:  

Year:  2011        PMID： 21796233      PMCID： PMC3142589     

Source DB:  PubMed          Journal:  Female Patient (Parsippany)        ISSN： 0888-2398


  7 in total

1.  Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.

Authors:  Guglielmo Ronco; Nereo Segnan; Paolo Giorgi-Rossi; Marco Zappa; Gian Piero Casadei; Francesca Carozzi; Paolo Dalla Palma; Annarosa Del Mistro; Stefania Folicaldi; Anna Gillio-Tos; Gaetano Nardo; Carlo Naldoni; Patrizia Schincaglia; Manuel Zorzi; Massimo Confortini; Jack Cuzick
Journal:  J Natl Cancer Inst       Date:  2006-06-07       Impact factor: 13.506

2.  HPV testing for primary cervical cancer screening.

Authors:  Guglielmo Ronco; Nereo Segnan
Journal:  Lancet       Date:  2007-10-04       Impact factor: 79.321

3.  ACOG Practice Bulletin no. 109: Cervical cytology screening.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

4.  Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.

Authors:  Mark H Einstein; Mark G Martens; Francisco A R Garcia; Daron G Ferris; Amy L Mitchell; Stephen P Day; Marilyn C Olson
Journal:  Gynecol Oncol       Date:  2010-05-21       Impact factor: 5.482

5.  Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.

Authors:  C A Perez; P W Grigsby; K S Chao; D G Mutch; M A Lockett
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-05-01       Impact factor: 7.038

Review 6.  Human papillomavirus infection and the primary and secondary prevention of cervical cancer.

Authors:  Douglas R Lowy; Diane Solomon; Allan Hildesheim; John T Schiller; Mark Schiffman
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

7.  Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial.

Authors:  N W J Bulkmans; J Berkhof; L Rozendaal; F J van Kemenade; A J P Boeke; S Bulk; F J Voorhorst; R H M Verheijen; K van Groningen; M E Boon; W Ruitinga; M van Ballegooijen; P J F Snijders; C J L M Meijer
Journal:  Lancet       Date:  2007-10-04       Impact factor: 79.321
  7 in total
  4 in total

1.  Cervical cancer knowledge and prevention among college women.

Authors:  Michael Wolwa; Cyril Blavo; Rushita Shah; Jay M Fleisher; Tania Espinal
Journal:  J Community Health       Date:  2013-12

2.  Antiproliferative and apoptotic potential of Glycyrrhizin against HPV16+ Caski cervical cancer cells: A plausible association with downreguation of HPV E6 and E7 oncogenes and Notch signaling pathway.

Authors:  Afza Ahmad; Rohit Kumar Tiwari; Prakriti Mishra; Ali G Alkhathami; Tahani M Almeleebia; Mohammad Y Alshahrani; Irfan Ahmad; Rawan Amer Asiri; Noura M Alabdullah; Mohamed Hussien; Mohd Saeed; Irfan Ahmad Ansari
Journal:  Saudi J Biol Sci       Date:  2022-01-31       Impact factor: 4.052

3.  Ormeloxifene nanotherapy for cervical cancer treatment.

Authors:  Neeraj Chauhan; Diane M Maher; Bilal B Hafeez; Hassan Mandil; Man M Singh; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Int J Nanomedicine       Date:  2019-09-03

4.  A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth.

Authors:  Neeraj Chauhan; Diane M Maher; Murali M Yallapu; Bilal B Hafeez; Man M Singh; Subhash C Chauhan; Meena Jaggi
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.